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ABSTRACT: Malaria, a mosquito-borne disease caused by
Plasmodium species, claims more than 400,000 lives globally each
year. The increasing drug resistance of the parasite renders the
development of new anti-malaria drugs necessary. Alternatively,
better delivery systems for already marketed drugs could help to
solve the resistance problem. Herein, we report glucose-based
ultra-small gold nanoparticles (Glc-NCs) that bind to cysteine-rich
domains of Plasmodium falciparum surface proteins. Microscopy
shows that Glc-NCs bind specifically to extracellular and all intra-
erythrocytic stages of P. falciparum. Glc-NCs may be used as drug
delivery agents as illustrated for ciprofloxacin, a poorly soluble
antibiotic with low antimalarial activity. Ciprofloxacin conjugated
to Glc-NCs is more water-soluble than the free drug and is more
potent. Glyco-gold nanoparticles that target cysteine-rich domains on parasites may be helpful for the prevention and treatment of
malaria.
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1. INTRODUCTION
Malaria is a mosquito-borne disease caused by protozoa of the
genus Plasmodium that remains a significant health burden.1
Five Plasmodium species can infect humans, but Plasmodium
falciparum (P. falciparum) is the most severe one. Efforts
toward malaria eradication have received much attention, while
incorrect diagnosis and resistance to conventional drugs pose a
major impediment. Resistance against all major classes of
drugs, 4-aminoquinolines (chloroquine, amodiaquine, and
piperaquine), antifolates, aryl amino-alcohols (quinine, lume-
fantrine, and mefloquine), artemisinin derivatives, antibiotics
(clindamycin and doxycycline), and napthoquinone (atova-
quone), has been reported.2 New malarial therapy or drug
delivery approaches using repurposed anti-infective drugs are
also alternative treatment options.3−5
Malaria symptoms appear during the blood stage of the P.
falciparum life cycle when merozoites are released from the
liver into the bloodstream. These merozoites invade red blood
cells (RBCs) and start a 48 h asexual developmental cycle
through rings, trophozoites, and schizonts. During this blood
life cycle, some of the parasites undergo gametocytogenesis,
where they develop into gametocytes that are responsible for
the transmission of the disease. Ideal drug delivery systems
target all these stages in the host.
One drug delivery strategy is based on the incorporation of
groups that bind to the targets on the parasite surface. The
merozoite surface is coated with proteins mediating human
erythrocyte invasion.6 Many of these surface proteins contain
cysteine-rich domains that play important roles during the
invasion process, such as the reticulocyte binding homolog 5
(PfRh5), the cysteine-rich protective antigen (CyRPA), the
erythrocyte-binding antigen-175 (EBA-175), the cysteine
repeat modular proteins (PfPCRMP1-2), or the Duffy-
binding-like erythrocyte-binding protein (DBL-EBP).7−12
Cysteine-rich domains are also expressed on the surface of
schizonts, gametocytes, and sporozoites P. falciparum.6,13,14
Thiols bind to gold nanoparticles to form strong bonds,15
and gold nanoparticles have been functionalized with cysteine
and used for cysteine detection.16−21 We developed glucose-
based ultra-small gold nanoparticles or gold nanoclusters (Glc-
NCs) to target cysteine-rich proteins on the surface of P.
falciparum. Glc-NCs were used without further functionaliza-
tion or tagged with a dye to gain insight into the binding to
different parasite stages. After specifically targeting intra-
erythrocytic stages of P. falciparum, Glc-NCs were loaded
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with ciprofloxacin to explore the inhibitory effect on the
parasites compared to the free drug. The significantly lower
50% inhibitory concentration (IC50) value of the drug-loaded
nanoparticles compared to the drug alone shows the
therapeutic potential of using gold nanoparticles as drug
delivery nanocarriers without the need for specific complex
targeting functionalities.
2. RESULTS AND DISCUSSION
2.1. Binding Assessment of Gold Nanoparticles to
Extracellular P. falciparum Parasites. P. falciparum was
chosen as a model to assess whether gold nanoparticles are
suitable to target cysteine-rich domains on surface proteins
since the erythrocytic cycle involves invasion of RBCs that are
not capable of performing endocytosis. In vitro experiments
inspecting the different intracellular parasite stages are less
Figure 1. Synthesis, characterization, and binding efficiency of gold nanoparticles to extracellular malaria parasites. (a) Synthesis of Glc-NCs.22 (b)
TEM image of 2 nm Glc-NCs (scale bar: 50 nm). (c) TEM image of 20 nm Cit-AuNPs (scale bar: 50 nm). (d) ICP-AES detection of Au bound to
extracellular parasites showed higher binding efficiency toward Glc-NCs when compared to Cit-AuNPs. ***P ≤ 0.001; ****P ≤ 0.0001.
Figure 2. Analysis of the binding of Glc-NCs to different blood stages of P. falciparum. (a) CLSM imaging of ATTO@Glc-NCs incubated for 15
min with infected RBCs showed specific binding of intracellular P. falciparum (red channel, ATTO647N; blue channel, DAPI; scale bar: 5 μm). (b)
FACS analysis of the binding of ATTO@Glc-NCs incubated for 15 min with highly synchronized P. falciparum cultures. Parasitemia was
determined using SYBR Green (FITC channel), and ATTO647N dye was detected to determine the binding of ATTO@Glc-NCs (APC channel).
****P ≤ 0.0001. (c) CLSM imaging of individual asexual erythrocyte stages incubated with ATTO@Glc-NCs showed specific binding for all the
stages (red channel, ATTO647N (ATTO@Glc-NCs); blue channel, DAPI; scale bar: 2 μm).
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complicated when compared to other parasite models that
require complex eukaryotic host cells. Initially, extracellular P.
falciparum parasites were used to analyze the binding affinity
toward gold nanoparticles of different sizes. For this,
intracellular schizonts were treated with saponin to lyse the
red blood cell hosts, leaving the mature extracellular parasites
intact. We synthesized and characterized citrate-stabilized gold
nanoparticles (Cit-AuNPs, 20 nm) and glucoside-based ultra-
small gold nanoparticles (Glc-NCs, 2 nm) (Figure 1a,b) to
investigate binding to extracellular P. falciparum.22 Both
nanoparticle samples were incubated at three concentrations
(5, 20, and 50 μM based on atomic gold) in PBS with
extracellular parasites for 15 min and washed with PBS buffer
to remove unbound nanoparticles. After treatment of the
parasites with aqua regia, inductively coupled plasma with
atomic emission spectrometry (ICP-AES) was used to
determine the concentration of gold in the samples. Binding
efficiency was further calculated based on the concentration of
bound gold with respect to the concentration of gold added to
the extracellular parasites. Both Cit-AuNPs and Glc-NCs were
detected in the parasite samples, proving the existing binding
affinity of the two gold nanoparticle samples toward
extracellular mature P. falciparum parasites (Figure 1c). Glc-
NCs bind much stronger than Cit-AuNPs. Possibly, the higher
surface area of Glc-NCs (2 nm) compared to Cit-AuNPs (20
nm) led to an increased accumulation on the parasites. In
addition, the hydroxyl groups of a glucose moiety stabilizing
them might engage in hydrogen bonding interactions with the
proteins.
2.2. Hemolytic Activity of Gold Nanoparticles. In order
to investigate if Glc-NCs could traverse the RBC membrane
and target the intracellular parasites, their hemolytic activity
was assessed. Different concentrations of Glc-NCs were
incubated with erythrocytes for 96 h but, even at the highest
concentration tested (20 μM), no hemolysis was observed
(Figure S1), demonstrating the safety of Glc-NCs to
mammalian cells.
2.3. Targeting Asynchronous Intracellular P. falcipa-
rum Parasites Using Gold Nanoparticles. The affinity of
Glc-NCs toward intracellular parasites was assessed. The
stability of Glc-NCs in P. falciparum culture medium was
investigated by TEM imaging. Overnight incubation of Glc-
NCs in protein-rich medium showed a particle size ranging 2−
5 nm (Figure S2a,b), proving that even though some
nanoparticles showed a small increase in size, Glc-NCs were
overall stable in growth medium. To detect the nanoparticles,
Glc-NCs were first tagged with the ATTO647N dye by
amidation using EDC/sulfo-NHS as coupling reagents to yield
ATTO@Glc-NCs (Figure S3). The fluorescently tagged gold
nanoparticles were then incubated for 15 min with
asynchronous cultures of infected RBCs. Uninfected RBCs
served as a control. The cultures were thoroughly washed and
incubated with DAPI that stains the parasites, as it is a nucleic
acid stain, but not RBCs that lack DNA. Confocal laser
scanning microscopy (CLSM) showed that Glc-NCs were able
to specifically bind intracellular P. falciparum (Figure 2a) but
not RBCs (Figure S4a). Non-conjugated ATTO647N dye was
also incubated with both uninfected and infected RBCs to rule
out unspecific binding to the dye, but no signal was observed
(Figure S4b,c).
2.4. Binding Assessment of Gold Nanoparticles to
Different Asexual Stages of P. falciparum. As mentioned
earlier, malaria parasites undergo maturation inside RBCs
through rings, trophozoites, and schizonts. The binding
efficacy was investigated in different erythrocytic stages. For
this experiment, highly synchronized P. falciparum cultures
were obtained using sorbitol, percoll, or magnetic separation.
These synchronized cultures at specific life stages were
incubated with ATTO@Glc-NCs, and binding was studied
by CLSM and flow cytometry (FACS) analysis. ATTO@Glc-
NCs bound all the asexual stages (rings, early and late
trophozoites, and schizonts) of intracellular P. falciparum,
according to CLSM (Figure 2c). FACS of highly synchronized
cultures at 5% parasitemia showed that binding increased
significantly from rings over trophozoites to schizonts as the
parasitic membrane proteins with cysteine-rich domains
increase (Figure 2b). Many Plasmodium membrane proteins
are involved in RBC invasion and are most abundant during
the later stages of intra-erythrocytic development.23 ATTO@
Glc-NCs did not significantly bind to uninfected RBCs.
Z-Stack confocal imaging was used to locate ATTO@Glc-
NCs on and inside schizonts, as DAPI (in blue) co-localized
with the tagged nanoclusters (in red) (Figure S5a). ATTO@
Glc-NCs interacted with the surface and penetrated the
parasite.
2.5. Binding Assessment of Gold Nanoparticles to P.
falciparum Gametocytes. Malaria transmission occurs via
the sexual blood stages, known as gametocytes. Gametocyto-
genesis can be induced in an in vitro culture under conditions
that involve high parasitemia and low hematocrit to simulate
Figure 3. CLSM images of gametocyte blood stages of P. falciparum incubated with ATTO@Glc-NCs (red channel, ATTO647N (ATTO@Glc-
NCs); blue channel, DAPI; left scale bars: 2 μm; right scale bars: 5 μm).
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anemia and the presence of human serum and N-acetyl-
glucosamine in the culture medium.24,25 ATTO@Glc-NCs
were incubated with intracellular sexual parasites using the
same conditions described for asexual stages. CLSM was used
to image the binding of ATTO@Glc-NCs to the different
sexual stages. ATTO@Glc-NCs were able to bind to stages I−
IV and even the isolated male and female gametocytes (stage
V) that are responsible for malaria transmission via uptake by
the mosquito during its meal (Figure 3). Stage IV gametocytes
were analyzed by Z-stack imaging in confocal microscopy
showing the interaction of ATTO@Glc-NCs with the surface
and the inside of the parasite, as the signal of the tagged
nanoclusters (in red) co-localized with the signal of the nuclei
of the parasites (in blue) (Figure S5b).
2.6. Synthesis and Characterization of Ciprofloxacin-
Conjugated Gold Nanoparticles. After showing that Glc-
NCs selectively bind all P. falciparum blood stages but not to
RBCs, we proceeded to study its ability to deliver drugs. Since
Glc-NCs can traverse directly into the RBC and bind the
parasite, they might show an improved inhibitory activity of
drug−nanoparticle conjugates. We selected ciprofloxacin, an
antibiotic that also has moderate antimalarial activity.26
Ciprofloxacin derivatives show enhanced antimalarial activity
when compared to the parent drug27−30 and potentiate the
effect of primaquine.31 Ciprofloxacin is soluble in acetic acid
but only slightly soluble in water and physiological buffers.32
The presence of a carboxylic acid (pKa 6.0) and a secondary
amine (pKa 8.8) provides two points for functionalization. The
isoelectric point of the zwitterionic form of ciprofloxacin is 7.4
and, at this pH, the molecule is least soluble.33 Conjugation of
ciprofloxacin to Glc-NCs aims to bypass the zwitterionic state,
reduce solubility problems, and ideally increase the therapeutic
activity by intracellular delivery into the parasite. Glc-NCs
were loaded with ciprofloxacin via the secondary amine to
yield Cipro@Glc-NCs (Figure 4a). After purification, FT-IR
analysis revealed the typical tertiary amide bond band at 1650
cm−1, indicating that the reaction succeeded (Figure S6). TEM
imaging showed that the nanoparticle size was 2 nm,
demonstrating that Cipro@Glc-NCs were stable after drug
conjugation (Figure 4b). The characteristic fluorescence
emission band of ciprofloxacin at 450 nm (Figure 4c, red
line) was visible in the Cipro@Glc-NCs sample (blue line) but
not in Glc-NCs (black line), indicating that the nanoparticle
loading succeeded. UV−Vis spectroscopy measurements
further showed that the typical bands for ciprofloxacin at
272, 325, and 335 nm were also present in the Cipro@Glc-
NCs sample (Figure 4d) and these bands could be further
exploited for drug quantification. The loading of ciprofloxacin
was quantified through a calibration curve, measuring the
absorbance of different ciprofloxacin standards as well as the
sample at 270 nm (Figure S7). The concentration of gold in
the sample was measured by ICP-AES, indicating 0.8 μM
ciprofloxacin/μM gold loading. The stability of Cipro@Glc-
NCs was tested by overnight incubation in protein-rich growth
medium. TEM imaging showed that the nanoparticle size
ranged from 2 to 6 nm, indicating only a slight increase in size
of some nanoparticles compared to the sample in water
(Figure S2c). The fully characterized Cipro@Glc-NCs sample
was used to inhibit P. falciparum.
2.7. Assessment of the Antimalarial Activity of
Ciprofloxacin-Conjugated Gold Nanoparticles. The
antimalarial activity of Cipro@Glc-NCs was compared to the
free drug, incubating different concentrations of Cipro@Glc-
NCs (concentration based on loaded ciprofloxacin), Glc-NCs,
ciprofloxacin, and artemisinin (as a positive control) with P.
falciparum for two life cycles (96 h). Parasitemia was assessed
using the SYBR Green method,34 quantified by fluorescence
spectroscopy and further plotted as dose−response curves
(Figure S8) to calculate IC50 values (Table 1). Glc-NCs did
not show an inhibitory effect on the parasites, as no IC50 value
could be obtained from the curves at the tested concentrations
(Figure S8c). Cipro@Glc-NCs showed a significantly lower
IC50 value (27.4 ± 3.8 μM) compared to ciprofloxacin alone
(157.9 ± 58.8 μM), demonstrating the importance of directed
drug delivery (Table S1). Even though the IC50 value of
artemisinin (positive control) is 1000-fold lower than Cipro@
Glc-NCs, the increasing resistance against this drug is a major
problem and the development of new antimalarial therapeutics
Figure 4. Synthesis and characterization of Cipro@Glc-NCs. (a) Synthetic scheme for the conjugation of ciprofloxacin to Glc-NCs leading to
Cipro@Glc-NCs. (b) TEM imaging of Cipro@Glc-NCs revealed a nanoparticle size of 2 nm (scale bar: 10 nm). (c) Fluorescence spectroscopy
showed an emission band at 450 nm for Cipro@Glc-NCs and ciprofloxacin but not for Glc-NCs. d) UV−Vis spectroscopy of Cipro@Glc-NCs
revealed bands at 270, 325, and 335 nm corresponding to ciprofloxacin showing successful nanoparticle functionalization.
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is needed. The enhanced therapeutic activity of ciprofloxacin
when using a nanoparticle formulation can be a result of the
increased accumulation of the drug on or in the P. falciparum
parasites in addition to the improved water solubility of
ciprofloxacin, as the free drug forms aggregates in aqueous
solutions.35 Gold nanoparticles are attractive drug nanocarriers
to specifically target cysteine-rich domains of surface proteins
on protozoan parasites (e.g., P. falciparum) and improve the
water solubility of hydrophobic drugs that lose efficacy as they
form aggregates in aqueous media.
3. CONCLUSIONS
In conclusion, after showing that two different types of gold
nanoparticles were able to bind extracellular P. falciparum,
ultra-small, glucose-based gold nanoparticles were utilized to
target all asexual and sexual erythrocytic stages of this
protozoan parasite without unspecific binding or lysing
RBCs. Gold nanoparticles likely interact with the protein via
cysteine-rich domains of P. falciparum surface proteins.
Ciprofloxacin-loaded nanoparticles rendered the moderate
antimalarial drug more water-soluble and improved its efficacy
against P. falciparum through a synergistic effect of selective
targeting, leading to drug accumulation on the parasite,
combined with better water solubility to prevent the formation
of drug aggregates. Nanoparticle uptake into cells offers a
significant advantage. Since these nanoparticles target all
parasite stages, gameticidal effects may also block transmission.
Minimal in vitro toxicity of glucose-based gold nanoparticles22
and anti-parasitic activity demonstrate the potential of easy-to-
synthesize gold nanoparticles as targeting devices. These
findings might herald a paradigm shift in the field of
antimalarials toward the use of gold nanoparticles as a
multipurpose antiplasmodial agent.
4. EXPERIMENTAL SECTION
4.1. Materials. All reagents were commercially purchased and
used without further purification. Ultrapure Millipore water (18.2
MΩ) was used as a solvent. All glassware was washed with Aqua Regia
(HCl/HNO3 in a 3:1 ratio by volume) and rinsed with ultrapure
water. Gold(III) chloride solution (30 wt % in dilute HCl) and 1-thio-
β-D-glucose sodium salt were purchased from Sigma Aldrich. RPMI
was purchased from Pan Biotech.
4.2. Instruments. Transmission electron microscopy (TEM)
measurements were performed on a Zeiss EM 912 Omega. The
samples were prepared by immersion of grids into a small volume of
the sample and subsequent solvent evaporation in a dust-protected
atmosphere.
UV/Vis spectra were recorded on a Shimadzu UV-3600
spectrophotometer double-beam UV−VIS−NIR spectrometer and
baseline-corrected.
ζ potential was measured using a Malvern Zetasizer instrument in
order to obtain the electrophoretic mobility of nanoparticles at
different times of dialysis against MilliQ water. The Helmholtz−
Smoluchowski equation was used to correlate the measured
electrophoretic mobilities to the zeta potentials. Three replicates of
each sample were measured six times at 25 °C in MilliQ water.
Confocal microscopy imaging was performed with a Zeiss LSM 710
confocal microscope system equipped with a 63× magnification,
numerical aperture 1.3 of Zeiss LCI Plan-NEOFLUAR water
immersion objective lens (Zeiss GmbH, Germany).
Flow cytometry (FACS) analysis was acquired on a FACSCanto II
flow cytometer (BD Biosciences, San Jose, CA, USA). The
fluorescence of 10,000 living single cells was analyzed after
monoparametric acquisition using an FITC height parameter
(excitation with a 488 nm blue laser, 585/42 nm emission filter)
and an APC height parameter (excitation with a 633 nm red laser,
660/20 nm emission filter). Data were analyzed with FlowJo analysis
software (Tree Star Inc., Ashland, OR).
Inductively coupled plasma atomic emission spectrometry (ICP-
AES) for gold concentration determination was performed on an
Optima 8000, Perkin Elmer, Massachusetts, USA. Samples were
diluted to a total volume of 5 mL using aqueous aqua regia. An
external calibration series from 0.1 to 5 mg/L was prepared using Au
standard solution. The average of three measurements was obtained,
and the initial dilution was back calculated.
4.3. Synthesis. 4.3.1. Synthesis of Glucose-Based Gold Nano-
clusters (Glc-NCs). As reported elsewhere,22 1-thio-β-D-glucose
sodium salt in MilliQ water (80.0 μL, 41.2 mM) was added to
HAuCl4 (1.0 mL, 2.9 mM) at room temperature. In a few seconds, a
change in color from yellow to brownish was observed, indicating the
formation of Glc-NCs. The solution was dialyzed in two cycles of 1.5
L of MilliQ water or filter-centrifuged using Amicon Ultra 15 mL
tubes (3000g, 30 min, three times).
4.3.2. Synthesis of Citrate-Stabilized Gold Nanoparticles (Cit-
AuNPs). As previously reported,36 a preheated solution of sodium
citrate (10 mL, 1%) in MilliQ water was added to a solution of
HAuCl4 (100 mL, 500 μM) in MilliQ water under boiling conditions
(100 °C). No refluxing was used to prevent the presence of
temperature gradients within the liquid. After 15 min, the red solution
was cooled to room temperature. The resulting Cit-AuNPs were
dialyzed against 1.5 L of MilliQ water three times.
4.3.3. Synthesis of ATTO-Tagged Glc-NCs (ATTO@Glc-NCs). A
solution of Glc-NCs (5.0 mL, 1.4 μmol of Au, 6.11 × 1015
nanoclusters) was diluted with 25 mL of MilliQ water and 500 μL
of PBS. To this solution, 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC, 6.5 mg, 34 μmol) and N-hydroxysulfosuccini-
mide (sulfo-NHS, 7.4 mg, 34 μmol) were added dropwise and the
reaction was allowed to stir for 5 min under sonication in an ice bath.
Subsequently, an aqueous solution of ATTO 647N dye (8.14 μL, 0.01
μmol) was added and allowed to react for 2 h under a cold sonication
bath. The resulting ATTO@Glc-NCs were dialyzed against 1.5 L of
MilliQ water three times.
4.3.4. Synthesis of Ciprofloxacin-Conjugated Glc-NCs (Cipro@
Glc-NCs). Commercially available ciprofloxacin hydrochloride (1.4
mg, 4.2 μmol) was first stirred with trimethylamine (TEA, ∼1 μL, 8.4
μmol) to completely solubilize the drug. The carboxylic acid groups of
Glc-NCs (0.42 μmol) were activated using 1-EDC (0.8 mg, 4.2 μmol)
and sulfo-NHS (0.9 mg, 4.2 μmol) for 5 min at room temperature. To
the activated Glc-NC solution in water, the mixture of ciprofloxacin
and TEA was added and sonicated for 2 h. The resultant solution was
dialyzed against MilliQ water overnight and filtered (0.45 μm filter) to
obtain the ciprofloxacin-conjugated nanoparticles (Cipro@Glc-NCs).
4.4. Biological Assays. 4.4.1. Cultivation of P. falciparum 3D7.
P. falciparum 3D7 erythrocyte stages were cultured as previously
reported.37 The asexual growth medium was composed of RPMI 1640
supplemented with 2 mM L-glutamine, 5 mM HEPES buffer, 28 μg/
mL hypoxanthine, 50 μg/mL gentamycin, and 0.5% AlbuMAX II. The
no-N-acetyl-glucosamine gametocyte medium (NNGM) was com-
posed of RPMI 1640 supplemented with 1 g of glucose, 28 μg/mL
hypoxanthine, 25 mM HEPES, and 0.5% AlbuMAX II. The N-acetyl-
glucosamine gametocyte medium (NGM) was composed of RPMI
1640 supplemented with 1 g of glucose, 28 μg/mL hypoxanthine, 25
mM HEPES, 5.8 g of N-acetyl-glucosamine, 0.5 mL of human serum,
and 0.5% AlbuMAX II. Parasites were kept at 1% hematocrit in 150
cm2 cell culture flasks at 37 °C under 5% CO2.
Table 1. IC50 Values Obtained from Incubation of Cipro@
Glc-NCs, Glc-NCs, Ciprofloxacin, and Artemisinin with P.










IC50 27.4 ± 3.8 157.9 ± 58.8 n.d.
a 14.9 ± 6.9
an.d. = not determined.
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Life cycle stages as well as parasitemia were determined daily by
light microscopy. For the microscope slide preparation, 1 mL of
resuspended culture was centrifuged for 5 min at 300g and the
supernatants were removed. The sample was smeared on the glass
slides by taking 7.5 μL of the blood pellet. The slides were then
allowed to dry and were further fixed with methanol. The parasites
were then stained with UN 1230 Giemsa staining solution, diluted to
6% (v/v) with staining buffer (7 mM phosphate, pH 7.1) for
visualization under the microscope. The P. falciparum gametocyte
stages were obtained by modification of a previously reported
protocol.25 Parasites were kept at 5% hematocrit in 10 cm Petri dishes
at 37 °C under 5% CO2, 5% O2, 90% N2, and 60% humidity.
For gametocyte induction, first asexual culturing and synchroniza-
tion were required in order to initiate log growth during the first 10
days. This asexual culturing was followed by gametocyte induction by
mimicking host anemia through total RBC replacement as well as by
reducing the hematocrit from 5 to 1.25%. A further increase in %
parasitemia also produced stressed parasites that induced gametocyto-
genesis. Once the gametocytes were induced, they were isolated
depending on the early or late stage. Early-stage gametocytes were
isolated by changing the asexual growth medium to NNGM and
doing percoll synchronization in NGM. Late-stage gametocytes were
isolated by changing the medium to NGM and doing percoll
synchronization using NGM instead of the asexual growth medium.
The gametocytes were then used for confocal microscopy imaging.
Parasites were further kept at 5% hematocrit in 10 cm Petri dishes at
37 °C under 5% CO2, 5% O2, 90% N2, and 60% humidity.
4.4.2. Sorbitol Synchronization of P. falciparum. Sorbitol
synchronization allows for enrichment of ring-stage parasites in
culture through lysis of most iRBCs containing mid and late
trophozoites as well as schizonts. The parasite cultures were
centrifuged for 5 min at 400g. The resulting pellet was resuspended
in five times the pellet volume of sterile and preheated 5% sorbitol
solution (in MilliQ water). Afterward, the cultures were incubated for
10 min at 37 °C and shaken every 3 min in a vortex mixer.
Subsequently, the cultures were washed twice (400g, 10 min) with
growth medium and transferred into a 150 cm2 cell culture flask
containing 60 mL of medium. Fresh RBCs were added to a final
hematocrit of 1%.
4.4.3. Magnetic Cell Separation for Schizont Enrichment. Since
the haem moiety in hemoglobin is diamagnetic, iRBCs containing
only mature parasites can be separated using magnetic-activated cell
sorting and LD columns. For this purpose, LD columns were placed
on a magnetic column holder and equilibrated using 2 mL of parasite
growth medium. The cultures were centrifuged at 300g for 5 min to
obtain the parasite pellets that were then loaded on the column
followed by 4 mL of growth medium. The flow through containing
RBCs and ring-stage iRBCs was collected, and the column containing
mature parasites was finally removed from the magnet and eluted with
2 mL of growth medium by applying pressure.
4.4.4. Percoll Synchronization of P. falciparum. Percoll
synchronization allows for enrichment of mature-stage parasites
(schizonts) in the culture in a similar way to magnetic cell separation.
The parasite cultures were centrifuged for 5 min at 300g. A solution of
percoll 70% in PBS was pre-warmed, and 1 mL of the pellet was
gently deposited on top of this solution (using 15 mL Falcon tubes).
This resulting mixture was subsequently centrifuged at 800g for 10
min at 37 °C, putting the acceleration and brake to minimum. The
resulting red upper layer was collected as it contains mature parasites
and washed extensively with growth medium (300g, 5 min). The
culture was then transferred into the culture flask or plate by adjusting
(when required) the hematocrit to 1%.
4.4.5. Saponin Isolation of P. falciparum Schizonts. Saponin
treatment leads to complete lysis of RBCs and allows for the isolation
of parasites. For this purpose, synchronized schizont stage cultures at
very high parasitemia (>50%) were used. The cultures were therefore
centrifuged (5 min, 400g) and resuspended in saponin solution (1
mL, 0.15%) and further incubated for 10 min in an ice bath, shaking
the cultures every 3 min using a vortex mixer. The suspension was
then centrifuged for 10 min at 2000g, maintaining the temperature at
4 °C, and the supernatant was discarded. The pellets were washed
several times with ice-cold PBS until the supernatant became clear.
4.4.6. ICP-AES Analysis. Isolated mature parasites (by saponin)
were thawed and washed with PBS (3000g, 5 min), and 500 μL of
PBS was added to resuspend the pellet. Three different concentrations
of Glc-NCs and Cit@AuNPs were used (5, 20, and 50 μM). For each
experiment, 20 μL of the resuspended parasites was incubated with 1
mL of each gold nanoparticle solution in PBS for 15 min. The
parasites were further washed three times with PBS (3000g, 5 min),
and the pellet was treated with aqua regia and measured with ICP-
AES.
4.4.7. Flow Cytometry. For parasitemia determination, as RBCs do
not contain DNA, the iRBCs can be distinguished by using a DNA-
staining dye (SYBR Green). For this purpose, 500 μL of a
resuspended culture (containing 5 μL of RBCs) was centrifuged
(300g, 5 min) and further washed with PBS. The pellet was then
resuspended in 150 μL of PBS. Finally, 1 mL of PBS containing 4%
PFA, 1 μL of the resuspended parasites, and a solution of SYBR
Green (dilution, 1:10,000) were incubated for 20 min in the absence
of light. Non-infected RBCs were used as a control. The measure-
ments were performed using an FITC channel.
4.4.8. Binding Studies with ATTO@Glc-NCs. The parasitemia of a
synchronized culture (rings, trophozoites, or schizonts) was
determined as previously described, adjusting it to 1 and 10%
parasitemia by adding fresh RBCs. The experiment was performed
using both % parasitemia. Then, 500 μL of a resuspended culture
(containing 5 μL of RBCs) and 5 μL of non-infected RBCs were
centrifuged (300g, 5 min) and further washed with PBS.
Subsequently, 1 mL of a dilution of ATTO@Glc-NCs (20 μM
concentration based on Au) in growth medium and PBS was added to
each sample. To prepare this solution, 500 μL of ATTO@Glc-NCs
(40 μM concentration based on Au) was diluted with 500 μL of
growth medium and 50 μL of 10× PBS. The diluted ATTO@Glc-
NCs were incubated with the parasites for 15 min under shaking and
in the dark. The parasites were then thoroughly washed three times
with PBS (300g, 5 min) and finally resuspended in 150 μL of PBS.
Subsequently, 1 mL of PBS containing 4% PFA, 1 μL of the
resuspended parasites, and a solution of SYBR Green (dilution,
1:10,000) were incubated for 20 min in the absence of light. Non-
infected RBCs were used as a control. The measurements were
performed using an FITC channel to detect parasitemia and APC
channel to detect ATTO@Glc-NCs. Non-infected RBCs (treated and
not treated with ATTO@Glc-NCs) and iRBC not treated with
ATTO@Glc-NCs were used as a control. Experiments were done in
triplicates.
4.4.9. Confocal Microscopy. For confocal imaging binding studies
of both asexual and sexual cultures, 500 μL of a resuspended culture
(containing 5 μL of RBCs) and 5 μL of non-infected RBCs were
centrifuged (300g, 5 min) and further washed with PBS.
Subsequently, 1 mL of a dilution of ATTO@Glc-NCs (20 μM
concentration based on Au) in growth medium and PBS was added to
each sample. To prepare this solution, 500 μL of ATTO@Glc-NCs
(40 μM concentration based on Au) was diluted with 500 μL of
growth medium and 50 μL of 10× PBS. The diluted ATTO@Glc-
NCs were incubated with the parasites for 15 min under shaking and
protected from light. The parasites were then thoroughly washed
three times with PBS (300g, 5 min) and finally fixed by incubation
with 500 μL of PBS containing 4% PFA for 15 min. Parasites were
then centrifuged one more time and resuspended in 30 μL of PBS. To
this suspension, 30 μL of mounting solution containing DAPI was
added and carefully mixed. Finally, 10 μL of this mixture was put on a
glass slide, covered with a glass cover, and fixed with nail polish. Non-
infected RBCs (treated and not treated with ATTO@Glc-NCs) and
iRBCs not treated with ATTO@Glc-NCs were used as a control.
4.4.10. Hemolysis Assay. A 96-well plate containing RBCs (1%
hematocrit) was incubated with serial dilutions of Glc-NCs in PBS
(20, 10, 5, 2.5, 1.3, 0.6, and 0.3 μM; concentration based on Au) in
triplicates for 96 h. The plate was then centrifuged (300g, 5 min), and
50 μL of the supernatants was put in a Greiner 96 V Bottom
Transparent Polystyrol in triplicates. The absorbance at 540 nm was
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read using a plate reader. Supernatants of RBCs treated with PBS
(negative control) and saponin (positive control) were also measured.
4.4.11. Stability of Glc-NCs and Cipro@Glc-NCs in Growth
Medium. Cipro@Glc-NCs (10 μg/mL) and Glc-NCs (10 μM) were
incubated overnight in RPMI media containing FBS (5%). The
samples were loaded on the TEM grids and subsequently washed by
dumping them on top of a water droplet for 15 min. The samples
were allowed to dry before TEM imaging.
4.4.12. Antimalarial Activity of Cipro@Glc-NCs against P.
falciparum. The antimalarial activity of Cipro@Glc-NCs was
determined following a procedure described elsewhere.34 For a
typical experiment, 50 μL of a P. falciparum culture at 1% parasitemia
and 4% hematocrit was incubated with 50 μL of different
concentrations of Cipro@Glc-NCs, ciprofloxacin, Glc-NCs, artemisi-
nin (positive control), and water (negative control) in a 96-well plate
at 37 °C for 96 h (two life cycles). Subsequently, 100 μL of lysis
buffer (20 mM Tris (pH 7.5), 5 mM EDTA, 0.008% (W/V) saponin,
and 0.08% (V/V) Triton X-100) containing SYBR Green (1:10,000)
was added to each well and the plate was incubated for 3 h at room
temperature in the dark. Fluorescence intensity was measured at 485
nm excitation and 528 nm emission using a Tecan microplate reader.
Fluorescence intensity plotted over log(concentration) was fitted in
OriginPro (OriginLab Corporation, Northampton, MA, USA) to a
sigmoidal dose−response curve where the inflection point corre-
sponds to the IC50 value.
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